Pioglitazone Actos Bladder Cancer Information
Posted on Saturday, September 17th, 2011 at 8:37 pm
In August 2011, the FDA published this Drug Safety Communication about adding safety information about Bladder Cancer to the label of drugs containing Pioglitazone. The following drugs contain Pioglitazone: Actos, Actoplus Met, Actoplus Met XR, Duetact.
The F.D. A. stated the following in the communication:
“The U.S. Food and Drug Administration (FDA) is informing the public that the Agency has approved updated drug labels for the pioglitazone-containing medicines to include safety information that the use of pioglitazone for more than one year may be associated with an increased risk of bladder cancer.”
If you or someone you know was prescribed Actos, Actoplus Met, Actoplus Met XR, Duetact and later developed Bladder Cancer, you may have a claim for money damages against the manufacturer of the drugs. Contact the Wilson Law Office for more information or for a Free Initial Consultation.
Call (662) 533-9111 to speak to an Intake Specialist 24 hours a day. An attorney will contact you by phone or letter after your initial information has been reviewed.